These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7796357)

  • 1. A randomized comparative study on the safety and efficacy of clarithromycin and erythromycin in treating community-acquired pneumonia.
    Jang TN; Liu CY; Wang FD; Yang SP; Fung CP
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Apr; 55(4):302-6. PubMed ID: 7796357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia.
    Anderson G; Esmonde TS; Coles S; Macklin J; Carnegie C
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():117-24. PubMed ID: 1827098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative efficacy and safety study of clarithromycin, roxithromycin and erythromycin stearate in mild pneumonia.
    Hatipoglu ON; Tasan Y
    Yonsei Med J; 2000 Jun; 41(3):340-4. PubMed ID: 10957888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group.
    Chien SM; Pichotta P; Siepman N; Chan CK
    Chest; 1993 Mar; 103(3):697-701. PubMed ID: 8449054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
    Lee PI; Wu MH; Huang LM; Chen JM; Lee CY
    J Microbiol Immunol Infect; 2008 Feb; 41(1):54-61. PubMed ID: 18327427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia.
    Ramirez J; Unowsky J; Talbot GH; Zhang H; Townsend L
    Clin Ther; 1999 Jan; 21(1):103-17. PubMed ID: 10090428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
    Skrepnek GH; Armstrong EP; Malone DC; Ramachandran S
    Curr Med Res Opin; 2005 Feb; 21(2):261-70. PubMed ID: 15801997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised, double-blind, double-dummy comparative study of gatifloxacin with clarithromycin in the treatment of community-acquired pneumonia.
    Lode H; Aronkyto T; Chuchalin AG; Jaaskevi M; Kahnovskii I; Kleutgens K;
    Clin Microbiol Infect; 2004 May; 10(5):403-8. PubMed ID: 15113316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization.
    Corrêa JC; Badaró R; Bumroongkit C; Mera JR; Dolmann AL; Juárez Martínez LG; Mayrinck LR; Tamez R; Yang JY
    Clin Ther; 2003 May; 25(5):1453-68. PubMed ID: 12867221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis of the safety of erythromycin compared to clarithromycin in adults and adolescents with pneumonia.
    Eljaaly K; Botaish A; Bahobail F; Almehmadi M; Assabban Z; Thabit AK; Alraddadi B; Aljabri A; Alqahtani N; Aseeri MA; Hashim A; Torres A
    J Chemother; 2020 Feb; 32(1):1-6. PubMed ID: 31650904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Notario G; Spiller J; Palmer R; Busman T
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial.
    Lebel MH; Mehra S
    Pediatr Infect Dis J; 2001 Dec; 20(12):1149-54. PubMed ID: 11740322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia.
    Poirier R
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():109-16. PubMed ID: 1827096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of erythromycin compared to clarithromycin and azithromycin in adults or adolescents with community-acquired pneumonia: A Systematic Review and meta-analysis of randomized controlled trials.
    Ashy N; Alharbi L; Alkhamisi R; Alradadi R; Eljaaly K
    J Infect Chemother; 2022 Aug; 28(8):1148-1152. PubMed ID: 35523718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
    Bradbury F
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():153-62. PubMed ID: 8396087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care.
    Dean NC; Sperry P; Wikler M; Suchyta MS; Hadlock C
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1164-9. PubMed ID: 16569825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of clarithromycin versus josamycin in the treatment of hospitalized patients with bacterial pneumonia.
    Straneo G; Scarpazza G
    J Int Med Res; 1990; 18(2):164-70. PubMed ID: 2140330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of clarithromycin in patients with Legionella pneumonia.
    Hamedani P; Ali J; Hafeez S; Bachand R; Dawood G; Quereshi S; Raza R; Yab Z
    Chest; 1991 Dec; 100(6):1503-6. PubMed ID: 1835689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.